Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Suwon
Clinical trial register · South Korea

Clinical Trials in Suwon, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seoul 195 Goyang-si 72 Daegu 59 Seongnam-si 59 Busan 50
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca37 Merck Sharp & Dohme LLC19 Novartis Pharmaceuticals13 Regeneron Pharmaceuticals12 AbbVie12 Clear sponsor filter
Site location
Seoul195 Goyang-si72 Daegu59 Seongnam-si59 Busan50
All 52 locations
Target enrolment
to

Trials with a site in Suwon

37 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
AstraZeneca
Phase 3
1,500
Busan, Daegu, Daejeon, Incheon, Seoul, Suwon
2026-08-20
Recruiting
AstraZeneca
Phase 3
4,500
Busan, Daegu, Goyang-si, Gyeonggi-do, Incheon, Jongno-gu, Seoul, Suwon
2026-06-29
Recruiting
AstraZeneca
Phase 3
1,100
Busan, Daegu, Goyang-si, Seongnam-si, Seoul, Suwon, Yangsan
2025-12-29
Recruiting
AstraZeneca
Phase 3
400
Goyang-si, Incheon, Seoul, Suwon
2025-10-31
Recruiting
AstraZeneca
Observational
130
Busan, Daejeon, Goyang-si, Guri-si, Incheon, Seongnam-si, Seoul, Suwon
2025-10-15
Recruiting
AstraZeneca
Phase 2
278
Cheongju-si, Namdong-gu, Seongnam-si, Seoul, Suwon
2025-08-07
Recruiting
AstraZeneca
Phase 3
800
Goyang-si, Gwangjin-gu, Seoul, Songpa-gu, Suwon
2025-08-01
Recruiting
Imjudo & Imfinzi PMS
NCT06544629Hepatocellular Carcinoma
AstraZeneca
Observational
246
Busan, Goyang, Seongnam, Seoul, Suwon
2025-04-14
Recruiting
AstraZeneca
Phase 3
600
Goyang-si, Seoul, Suwon
2025-03-27
Recruiting
AstraZeneca
Phase 3
11,300
Bucheon-si, Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon, Wŏnju, Yangsan
2025-03-14
Recruiting
AstraZeneca
Phase 3
1,160
Changwon-si, Cheongju-si, Incheon, JinJoo, Seoul, Suwon
2024-11-18
Recruiting
AstraZeneca
Phase 3
744
Busan, Chungcheongbuk-do, Goyang-si, Gyeonggi-do, Jinju, Seoul, Suwon
2024-10-04
Active, closed
AstraZeneca
Phase 2
194
Seongnam, Seoul, Suwon
2024-08-27
Recruiting
AstraZeneca
Phase 2
80
Busan, Daegu, Gyeongsangnam-do, Incheon, Jeonju, Seogu, Seoul, Suwon
2024-07-16
Recruiting
AstraZeneca
Phase 3
582
Goyang-si, Namdong-gu, Seoul, Suwon
2024-04-29
Active, closed
AstraZeneca
Phase 2
76
Cheongju-si, Seongnam-si, Seoul, Suwon
2024-04-21
Recruiting
AstraZeneca
Phase 3
675
Changwon, Incheon, Seongnam-si, Seoul, Suwon
2024-04-11
Recruiting
AstraZeneca
Phase 3
1,145
Goyang-si, Gyeonggi-do, Incheon, Seoul, Suwon
2023-12-14
Active, closed
AstraZeneca
Phase 3
1,898
Daejeon, Seongnam-si, Seoul, Suwon
2023-11-21
Active, closed
AstraZeneca
Phase 3
895
Cheongju-si, Incheon, Jinju, Seoul, Suwon
2023-10-24
Active, closed
AstraZeneca
Phase 3
1,350
Busan, Cheongju-si, Jinju, Seoul, Suwon
2022-12-29
Active, closed
AstraZeneca
Phase 3
594
Cheongju-si, Seoul, Suwon
2022-09-15
Active, closed
AstraZeneca
Phase 3
341
Goyang-si, Gyeonggi-do, Jinju, Seoul, Suwon
2022-08-03
Recruiting
AstraZeneca
Phase 2
630
Busan, Chungcheongbuk-do, Seongnam-si, Seoul, Suwon
2022-04-14
Active, closed
AstraZeneca
Phase 3
390
Daegu, Jinju, Seoul, Suwon
2022-02-21
Active, closed
AstraZeneca
Phase 3
791
Daegu, Goyang-si, Incheon, Jinju, Seoul, Suwon
2022-02-18
Active, closed
AstraZeneca
Phase 3
1,051
Changwon-si, Cheongju-si, Seongnam-si, Seoul, Suwon
2022-02-07
Active, closed
AstraZeneca
Phase 3
640
Daegu, Seoul, Suwon
2020-10-19
Active, closed
AstraZeneca
Phase 3
805
Goyang-si, Seoul, Suwon, Yangsan
2020-05-05
Active, closed
AstraZeneca
Phase 3
818
Busan, Daegu, Goyang-si, Incheon, Seongnam-si, Seoul, Suwon
2020-04-16
Active, closed
AstraZeneca
Phase 2
367
Goyang-si, Seongnam-si, Seoul, Suwon
2019-01-09
Active, closed
AstraZeneca
Phase 3
1,407
Goyang-si, Seongnam-si, Seoul, Suwon
2019-01-04
Active, closed
AstraZeneca
Phase 3
825
Busan, Cheongju-si, Seongnam-si, Seoul, Suwon
2018-12-06
Active, closed
AstraZeneca
Phase 3
730
Changwon-si, Cheongju-si, Daegu, Goyang-si, Jinju, Seongnam-si, Seoul, Suwon
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Goyang-si, Incheon, Seoul, Suwon
2018-09-27
Active, closed
AstraZeneca
Phase 3
669
Changwon-si, Cheongju-si, Daegu, Incheon, Jinju, Seoul, Suwon
2017-01-02
Active, closed
AstraZeneca
Phase 3
682
Cheongju-si, Seoul, Suwon
2015-10-21
Rows per page Showing 1–37 of 37
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/suwon

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 37 of those studies with a site in Suwon that also match the filters currently applied.

How many clinical trials are recruiting in Suwon?

17 of the 37 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 20 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Suwon), 37 studies
PhaseStudiesRecruitingShare
Phase 3291278.4%
Phase 26316.2%
Observational225.4%

Most active sponsors

Lead sponsors with the most studies (Suwon)
Lead sponsorStudiesRecruiting
AstraZeneca3717
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.